.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Harney Brothers Cannabis is stocked at 183 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Queens, Buffalo, and Staten Island. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, Harney Brothers Cannabis concentrated 63.54% of sales in Beverage, where category sales grew 152.76% year over year but fell 12.64% month over month; Pre-Roll held 19.73% share with 10.80% YoY growth and a 10.83% MoM decline. Tincture & Sublingual reached 9.08% share with 22.52% YoY growth and a 4.87% MoM decline, while Flower slid to 7.41% share with an 84.81% YoY drop and a 43.53% MoM decline; Edible was 0.24% share, down 71.53% YoY and 33.98% MoM. The mix implies deliberate pivoting toward Beverage and away from Flower, with Beverage now the top category in New York channel-mix terms and a rank position of 3 in Beverage reinforcing focus despite MoM pullback.
The steep 54.08% YoY decrease in average price alongside a 0.84% YoY dip in total brand sales and a 32.71% two-year lift indicates a price-access strategy that is expanding category reach while compressing per-unit revenue; the 12.64% Beverage MoM decline paired with a 43.53% Flower MoM decline suggests short-term volume risk is concentrated in legacy inhalables rather than the Beverage growth engine. With Beverage at 63.54% share and ranked 3 in Beverage in New York, the brand is positioning as a value-forward Beverage specialist, using Tincture & Sublingual’s 22.52% YoY growth as an adjacent upsell while Pre-Roll’s 10.80% YoY lift supports trial without offsetting the intentional retreat from Flower.
Competitive Landscape
Harney Brothers Cannabis ranks #3 in NY Beverage in September 2026, improving 2 positions year over year from #5, while holding the same #3 spot since June–September 2026, and this stability contrasts with Layup sitting at #2 with a 33.7% YoY sales increase and Ayrloom fixed at #1 despite a −2.0% YoY sales decline. Relative pressure is building below as High Peaks remains #4 with 63.9% YoY sales growth while Tune slid from #3 to #5 on a −7.8% YoY sales decline, implying Harney Brothers Cannabis’s ascent to a peak rank of #3 in September 2026 positions it as a stable top-three incumbent that must either convert share from a declining #1 or fend off a fast-growing #4.
Notable Products
The steepest decline came from CBD/THC 1:1 Peach Black Tea (10mg CBD, 10mg THC, 16oz), down 23.7% MoM and sitting at rank 3, while CBD/THC 1:1 Hibiscus Herbal Tea (10mg CBD, 10mg THC, 16oz) fell 18.2% to rank 1. Across the top ten, eight SKUs are Beverages and six of those posted double-digit MoM drops between 10.4% and 23.7%, whereas CBD/THC 1:1 Half Baked Lemonade & Tea (10mg CBD, 10mg THC, 16oz) in rank 2 was a rare gainer at +1.2%. The lone non-Beverage, Sour Diesel Pre-Roll (1g), ranked 5 and declined 20.4% MoM, indicating weakness outside the beverage core and no offsetting lift from adjacent formats. This mix implies Harney Brothers Cannabis is concentrated in 1:1 Beverage SKUs that are cycling down in September 2026, pointing to a need for flavor rotation or promotional support to stabilize share.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
